Reports
Sale
Global Viral Clearance Market Share, Size, Forecast: By Method: Viral Removal Method, Viral Inactivation Method; By Application: Recombinant Proteins, Vaccines, Blood and Blood Products, Cellular and Gene Therapy Products, Others; By End Use; Regional Analysis; Competitive Landscape; Key Trends and Developments in the Market; 2023-2028
Global Viral Clearance Market Outlook
The global viral clearance market would likely grow at a CAGR of 9.6% during 2023-2028. Viral contamination poses a common but significant threat to human and animal-derived biopharmaceuticals. Such contamination may affect any phase of a bioproduction process, and biomanufacturers must carry out viral testing studies and include viral clearance methods into their procedures.
Viral clearance refers to removal of viral contamination with the help of specialized membranes (generally proteins) or chromatography. To ensure that therapeutic drugs drawn from particular sources are free of viral contamination, protein solutions go through viral clearance to remove or inactivate viral material. Asia Pacific, North America and Europe are likely to be key markets.
Global Market Likely to be Driven by Need to Ensure Biopharmaceutical Product Safety
Viral clearance studies are important to manufacturers’ programs to ensure product safety. Producers of biopharmaceutical products or auxiliary material drawn from human or animal tissue are needed to exhibit the capability of their purification and production processes to inactivate or remove viruses or TSE agents and ascertain product safety.
Most viral contaminations associated with raw materials are linked with the use of materials drawn from animals. Materials like trypsin, serum, plasma proteins, and tissue and protein extracts may possibly carry viral contaminants. Among non-animal raw materials, glucose has the greatest risk of viral contamination in the upstream process, if a chemically defined medium is employed.
Examples of human or animal tissue-driven products include recombinant proteins, blood products, polyclonal antibodies, hormones, enzymes, and medical devices that carry animal or human blood-derived elements.
Leading Companies Offer Sophisticated Solutions to Meet Client Needs
Leading companies hold significant databases of thousands of studies conducted for clients that guide their ability to execute, develop, and assess the viral/TSE clearance studies that best fulfil client requirement.
Companies like Syngene offer viral testing and clearance services catering to client needs to fulfil the viral safety requirements of their Biologics programs. Such services are expected to boost the global viral clearance market.
Texcell provides diverse alternatives for quality data for regulatory submissions. The company defines investigational Viral Clearance studies as For Information Only or “FIO”, and customizes them to be quick, economical, and offer the most vital info required to design a robust GLP Viral Clearance. Viral Clearance products experience include, among others, recombinant proteins, monoclonal antibodies, ortho biologics, gene therapy products, bone, tissues, and collagen, blood products, nanoparticles, and vaccines.
Organizations like Eurofins BioPharma offer Viral Clearance Services that include several types of validated and well characterized viral stocks to support animal and human-derived products.
In 2020, Merck expanded BioReliance® Viral Clearance offering in Singapore to save customers’ time. The services would enable customers to carry out viral clearance studies that ensured the quality and safety of their biological drugs during the clinical development process. Such services are expected to boost the global viral clearance market.
Market Segmentation
By method, the market is divided into:
- Viral Removal Method
- Viral Inactivation Method
By application, the market is segmented into:
- Recombinant Proteins
- Vaccines
- Blood and Blood Products
- Cellular and Gene Therapy Products
- Others
By end use, the global viral clearance market is classified into;
- Contract Research Organisation (CRO)
- Pharmaceutical and Biotech Industry
- Academic Research Institutes
- Others
By region, the market is segmented into:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Key Industry Players in the Market
The report offers an extensive assessment of major players in the global viral clearance market; it evaluates their capability, observes latest occurrences such as mergers and acquisitions, capacity expansions, and plant turnarounds:
- Merck KGaA
- WuXi AppTec Co., Ltd
- Charles River Laboratories International, Inc.
- Texcell SA
- Vironova AB
- Sartorius AG
- Syngene International Limited
- Creative Biogene
- Eurofins Scientific
- Others
Using SWOT analysis and Porter’s Five Forces model, the EMR report offers deep insights into the industry.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Method |
|
| Breakup by Application |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Viral Clearance Market Analysis
8.1 Key Industry Highlights
8.2 Global Viral Clearance Historical Market (2018-2022)
8.3 Global Viral Clearance Market Forecast (2023-2028)
8.4 Global Viral Clearance Market by Method
8.4.1 Viral Removal Method
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Viral Inactivation Method
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.5 Global Viral Clearance Market by Application
8.5.1 Recombinant Proteins
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Vaccines
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Blood and Blood Products
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Cellular and Gene Therapy Products
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2018-2022)
8.5.4.3 Forecast Trend (2023-2028)
8.5.5 Others
8.6 Global Viral Clearance Market by End Use
8.6.1 Contract Research Organisation (CRO)
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Pharmaceutical and Biotech Industry
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Academic Research Institutes
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.6.4 Others
8.7 Global Viral Clearance Market by Region
8.7.1 North America
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2018-2022)
8.7.1.3 Forecast Trend (2023-2028)
8.7.2 Europe
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2018-2022)
8.7.2.3 Forecast Trend (2023-2028)
8.7.3 Asia Pacific
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2018-2022)
8.7.3.3 Forecast Trend (2023-2028)
8.7.4 Latin America
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2018-2022)
8.7.4.3 Forecast Trend (2023-2028)
8.7.5 Middle East and Africa
8.7.5.1 Market Share
8.7.5.2 Historical Trend (2018-2022)
8.7.5.3 Forecast Trend (2023-2028)
9 North America Viral Clearance Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2022)
9.1.3 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2022)
9.2.3 Forecast Trend (2023-2028)
10 Europe Viral Clearance Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Viral Clearance Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Viral Clearance Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Viral Clearance Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2022)
13.4.3 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Merck KGaA
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 WuXi AppTec Co., Ltd
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Charles River Laboratories International, Inc.
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Texcell SA
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Vironova AB
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Sartorius AG
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Syngene International Limited
15.2.7.1 Company Overview
15.2.7.2 Product Portfolio
15.2.7.3 Demographic Reach and Achievements
15.2.7.4 Certifications
15.2.8 Creative Biogene
15.2.8.1 Company Overview
15.2.8.2 Product Portfolio
15.2.8.3 Demographic Reach and Achievements
15.2.8.4 Certifications
15.2.9 Eurofins Scientific
15.2.9.1 Company Overview
15.2.9.2 Product Portfolio
15.2.9.3 Demographic Reach and Achievements
15.2.9.4 Certifications
15.2.10 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Viral Clearance Market: Key Industry Highlights, 2017 and 2021
2. Global Viral Clearance Historical Market: Breakup by Method (USD Million), 2018-2022
3. Global Viral Clearance Market Forecast: Breakup by Method (USD Million), 2023-2028
4. Global Viral Clearance Historical Market: Breakup by Application (USD Million), 2018-2022
5. Global Viral Clearance Market Forecast: Breakup by Application (USD Million), 2023-2028
6. Global Viral Clearance Historical Market: Breakup by End User (USD Million), 2018-2022
7. Global Viral Clearance Market Forecast: Breakup by End User (USD Million), 2023-2028
8. Global Viral Clearance Historical Market: Breakup by Region (USD Million), 2018-2022
9. Global Viral Clearance Market Forecast: Breakup by Region (USD Million), 2023-2028
10. North America Viral Clearance Historical Market: Breakup by Country (USD Million), 2018-2022
11. North America Viral Clearance Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Europe Viral Clearance Historical Market: Breakup by Country (USD Million), 2018-2022
13. Europe Viral Clearance Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Asia Pacific Viral Clearance Historical Market: Breakup by Country (USD Million), 2018-2022
15. Asia Pacific Viral Clearance Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Latin America Viral Clearance Historical Market: Breakup by Country (USD Million), 2018-2022
17. Latin America Viral Clearance Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Middle East and Africa Viral Clearance Historical Market: Breakup by Country (USD Million), 2018-2022
19. Middle East and Africa Viral Clearance Market Forecast: Breakup by Country (USD Million), 2023-2028
20. Global Viral Clearance Market Structure
Key Questions Answered in the Report
The market is estimated to grow at a CAGR of 9.6% in the forecast period of between 2023 and 2028.
The major drivers of the market include the increasing application of viral clearance methods in pharmaceutical and biotechnological industries, rising cases of viral contaminations in animal and human-derived products, and growing health awareness.
The growing research and development activities by the pharmaceutical manufacturers and stringent regulations by various governments aimed towards bolstering safety standards, are the key trends in the market.
Viral removal method and viral inactivation method are the primary methods for viral clearance.
The different applications of viral clearance are recombinant proteins, vaccines, blood and blood products, and cellular and gene therapy products, among others.
The major players in the viral clearance market are Merck KGaA, WuXi AppTec Co., Ltd, Charles River Laboratories International, Inc., Texcell SA, Vironova AB, Sartorius AG, Syngene International Limited, Creative Biogene, and Eurofins Scientific, among others.
The cytotoxic cell, which is known to be a T-cell, is a common cause of viral clearance.
Viral clearance is important because various types of viral clearance methods reduce the risk of harmful contamination of viruses.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 2199
$1799
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$3199$2999-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$4199$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$5199$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER